PRESS: GlaxoSmithKline And Sanofi Near GBP500 Million UK Vaccine Deal

(Alliance News) - GlaxoSmithKline PLC and Sanofi SA are close to an agreement to supply the UK ...

Alliance News 5 July, 2020 | 2:51PM
Email Form

(Alliance News) - GlaxoSmithKline PLC and Sanofi SA are close to an agreement to supply the UK government with the Covid-19 vaccine that the two pharmaceutical giants are developing, the Sunday Times reported.

The deal to supply 60 million doses of coronavirus vaccine would be worth GBP500 million, the newspaper said.

The UK business department as taken an option to buy the as-yet unproven vaccine should it work in human trials due to begin in September, according to the Times.

The agreement with the UK and French companies is part of a scramble to secure vaccine supplies, as the US bought most of the world's supply of remdesivir, an antiviral drug made by Foster City, California-based Gilead Sciences Inc, the Times noted.

By Tom Waite;

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
GlaxoSmithKline PLC 1,410.40
Sanofi SA 83.23
Gilead Sciences Inc 67.07

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies